Royal London Asset Management Ltd. cut its stake in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 1.5% in the 2nd quarter, Holdings Channel reports. The fund owned 27,828 shares of the medical equipment provider’s stock after selling 438 shares during the quarter. Royal London Asset Management Ltd.’s holdings in Align Technology were worth $6,719,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Moody National Bank Trust Division raised its stake in Align Technology by 1.8% during the 1st quarter. Moody National Bank Trust Division now owns 2,107 shares of the medical equipment provider’s stock valued at $691,000 after acquiring an additional 38 shares during the last quarter. Mather Group LLC. raised its stake in Align Technology by 52.5% during the 2nd quarter. Mather Group LLC. now owns 122 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 42 shares during the last quarter. Crewe Advisors LLC raised its stake in Align Technology by 36.8% during the 2nd quarter. Crewe Advisors LLC now owns 171 shares of the medical equipment provider’s stock valued at $41,000 after acquiring an additional 46 shares during the last quarter. Czech National Bank raised its stake in Align Technology by 0.5% during the 1st quarter. Czech National Bank now owns 12,532 shares of the medical equipment provider’s stock valued at $4,109,000 after acquiring an additional 57 shares during the last quarter. Finally, Wedmont Private Capital raised its stake in Align Technology by 4.8% during the 1st quarter. Wedmont Private Capital now owns 1,250 shares of the medical equipment provider’s stock valued at $413,000 after acquiring an additional 57 shares during the last quarter. 88.43% of the stock is owned by hedge funds and other institutional investors.
Align Technology Trading Up 6.5 %
Shares of ALGN opened at $243.73 on Friday. The firm has a market capitalization of $18.21 billion, a P/E ratio of 40.15, a price-to-earnings-growth ratio of 5.13 and a beta of 1.64. The stock’s fifty day simple moving average is $232.08 and its 200 day simple moving average is $266.66. Align Technology, Inc. has a twelve month low of $176.34 and a twelve month high of $335.73.
Insider Buying and Selling at Align Technology
In related news, Director C Raymond Larkin, Jr. acquired 6,500 shares of the business’s stock in a transaction on Thursday, August 15th. The shares were bought at an average cost of $235.33 per share, with a total value of $1,529,645.00. Following the completion of the transaction, the director now directly owns 28,247 shares of the company’s stock, valued at approximately $6,647,366.51. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.62% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
Several analysts have commented on ALGN shares. Evercore ISI reduced their price objective on Align Technology from $370.00 to $300.00 and set an “outperform” rating for the company in a research note on Monday, June 10th. StockNews.com downgraded Align Technology from a “buy” rating to a “hold” rating in a research note on Sunday, September 1st. OTR Global reissued a “mixed” rating on shares of Align Technology in a research note on Tuesday, June 4th. Morgan Stanley cut their target price on Align Technology from $328.00 to $310.00 and set an “overweight” rating for the company in a research note on Thursday, July 25th. Finally, Robert W. Baird cut their target price on Align Technology from $370.00 to $325.00 and set an “outperform” rating for the company in a research note on Monday, July 22nd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $306.88.
Get Our Latest Analysis on ALGN
About Align Technology
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Further Reading
- Five stocks we like better than Align Technology
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- Find and Profitably Trade Stocks at 52-Week Lows
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- Investing in Commodities: What Are They? How to Invest in Them
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.